Development of enzyme-linked immunosorbent assays for the detection of myositis-specific autoantibodies against signal recognition particle, nuclear matrix protein 2, and small ubiquitin-like modifier activating enzyme
The newly developed ELISA systems showed excellent agreement with IP assays, supporting their applicability for routine clinical use in detecting anti-SRP, anti-NXP2, and anti-SAE autoantibodies.
Authors
- S. Sato
- Hiroki Abe (ORCID: https://orcid.org/0000-0002-7507-3381)
- Akihiro Murakami
- Yukihiro Nishikawa (ORCID: https://orcid.org/0000-0002-0739-8491)
- Ran Nakashima (ORCID: https://orcid.org/0000-0001-6247-0647)
- Shun Matsuzawa (ORCID: https://orcid.org/0000-0002-3088-2273)
- Takuya Isayama
- Masataka Kuwana (ORCID: https://orcid.org/0000-0003-1249-985X)
- Manabu Fujimoto
- Naoko Okiyama
- Shunsuke Kidani
- Ichizo Nishino
- Tetsuya Kikuchi
Institutions
- Tokyo Medical and Dental University (JP)
- Tokai University (JP)
- Kyoto University (JP)
- Osaka City University (JP)
- National Center of Neurology and Psychiatry (JP)
- Medical & Biological Laboratories (Japan) (JP)
- Nippon Medical School Hospital (JP)
- Nippon Medical School (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- Modern Rheumatology
- Published
- 2026-02-09
- DOI
- https://doi.org/10.1093/mr/roag003
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 0.00